Amgen Inc.AMGN0.36%increase; green up pointing triangle on Friday reported widely anticipated data on its new cholesterol-lowering drug Repatha, showing it reduced the risk of deaths, heart ...

A federal appeals court has rejected a bid by Amgen Inc to revive patents on its cholesterol drug Repatha after they were ruled invalid by a district court, a victory for Regeneron Pharmaceuticals ...